Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Debt Ratio: 2010-2025

Historic Debt Ratio for Cytokinetics (CYTK) over the last 10 years, with Sep 2025 value amounting to 0.12.

  • Cytokinetics' Debt Ratio rose 66.77% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year increase of 66.77%. This contributed to the annual value of 0.07 for FY2024, which is 10.02% down from last year.
  • As of Q3 2025, Cytokinetics' Debt Ratio stood at 0.12, which was down 14.99% from 0.14 recorded in Q2 2025.
  • Over the past 5 years, Cytokinetics' Debt Ratio peaked at 0.14 during Q2 2025, and registered a low of 0.06 during Q4 2021.
  • For the 3-year period, Cytokinetics' Debt Ratio averaged around 0.09, with its median value being 0.08 (2023).
  • Its Debt Ratio has fluctuated over the past 5 years, first slumped by 57.75% in 2021, then spiked by 107.14% in 2025.
  • Quarterly analysis of 5 years shows Cytokinetics' Debt Ratio stood at 0.06 in 2021, then grew by 13.36% to 0.06 in 2022, then soared by 30.13% to 0.08 in 2023, then decreased by 10.02% to 0.07 in 2024, then surged by 66.77% to 0.12 in 2025.
  • Its Debt Ratio stands at 0.12 for Q3 2025, versus 0.14 for Q2 2025 and 0.08 for Q1 2025.